Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future

Michele Buemi, Carmela Aloisi, Floccari Fulvio, Chiara Caccamo, Emanuela Cavallaro, Eleonora Crascì, Manila Criseo, Francesco Corica, Nicola Frisina

Research output: Contribution to journalArticle

Abstract

Complications from atherosclerosis cause most deaths in western countries, and their incidence appears to be markedly increasing in developing countries, thus suggesting a correlation that is directly proportional to social progress. In recent years, the different branches of medical research, from studies on vascular disease to those on lipid and glucose metabolism, and also clinical research on coronary, carotid and peripheral artery diseases, epidemiologic and pharmacologic research, have concentrated on these diseases with the common aim of reducing the incidence of cardiovascular diseases, and mortality. Scientific progress has greatly improved our understanding of the pathogenic mechanisms underlying the progression of cardiovascular disease, and efforts in this discipline now appear more necessary than ever.

Original languageEnglish
Pages (from-to)3973-3984
Number of pages12
JournalCurrent Pharmaceutical Design
Volume11
Issue number30
DOIs
Publication statusPublished - 2005

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future'. Together they form a unique fingerprint.

  • Cite this

    Buemi, M., Aloisi, C., Fulvio, F., Caccamo, C., Cavallaro, E., Crascì, E., Criseo, M., Corica, F., & Frisina, N. (2005). Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future. Current Pharmaceutical Design, 11(30), 3973-3984. https://doi.org/10.2174/138161205774580589